Total Payments
$7,596
2024 Payments
$2,044
Companies
20
Transactions
155
Medicare Patients
2,917
Medicare Billing
$303,581
Payment Breakdown by Category
Food & Beverage$3,598 (47.4%)
Other$2,500 (32.9%)
Consulting$1,350 (17.8%)
Education$148.39 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,598 | 151 | 47.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $2,500 | 1 | 32.9% |
| Consulting Fee | $1,350 | 1 | 17.8% |
| Education | $148.39 | 2 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Respicardia, Inc. | $2,500 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $1,806 | 76 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $1,668 | 8 | $0 (2024) |
| Electromed, Inc. | $228.60 | 14 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $187.29 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $173.87 | 8 | $0 (2024) |
| United Therapeutics Corporation | $134.20 | 6 | $0 (2024) |
| Axsome Therapeutics, Inc. | $133.51 | 6 | $0 (2024) |
| GENZYME CORPORATION | $132.18 | 6 | $0 (2024) |
| Mylan Specialty L.P. | $128.58 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,044 | 83 | AstraZeneca Pharmaceuticals LP ($997.55) |
| 2023 | $1,401 | 65 | AstraZeneca Pharmaceuticals LP ($808.60) |
| 2022 | $55.47 | 3 | Axsome Therapeutics, Inc. ($22.50) |
| 2020 | $1,497 | 2 | Harmony Biosciences LLC ($1,497) |
| 2019 | $2,500 | 1 | Respicardia, Inc. ($2,500) |
| 2017 | $97.97 | 1 | Jazz Pharmaceuticals Inc. ($97.97) |
All Payment Transactions
155 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Respiratory | ||||||
| 12/23/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $19.65 | General |
| Category: HFCWO | ||||||
| 12/18/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $34.90 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $32.71 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $24.61 | General |
| Category: Narcoplepsy | ||||||
| 11/04/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $21.04 | General |
| Category: HFCWO | ||||||
| 10/24/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Immunology | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $31.39 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $15.98 | General |
| Category: HFCWO | ||||||
| 10/03/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $2.54 | General |
| Category: HFCWO | ||||||
| 10/01/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: NEUROLOGY | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $34.66 | General |
| Category: Respiratory | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Respiratory | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Respiratory | ||||||
| 09/09/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $17.47 | General |
| Category: HFCWO | ||||||
| 09/05/2024 | Resmed Corp | AIRSENSE (Device) | Education | Cash or cash equivalent | $93.40 | General |
| Category: Sleep | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Respiratory | ||||||
| 08/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 739 | 915 | $354,716 | $78,025 |
| 2022 | 9 | 489 | 584 | $161,431 | $54,999 |
| 2021 | 13 | 702 | 813 | $206,714 | $71,371 |
| 2020 | 10 | 987 | 1,226 | $288,523 | $99,187 |
Total Patients
2,917
Total Services
3,538
Medicare Billing
$303,581
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 80 | 165 | $54,612 | $15,604 | 28.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 32 | 59 | $39,871 | $10,021 | 25.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 61 | 65 | $40,825 | $9,017 | 22.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 59 | 64 | $34,884 | $8,864 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 95 | $33,622 | $8,834 | 26.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $28,680 | $7,188 | 25.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 46 | 78 | $16,997 | $4,913 | 28.9% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 130 | 131 | $70,085 | $4,157 | 5.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 62 | $13,780 | $3,257 | 23.6% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 21 | 21 | $5,124 | $1,956 | 38.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 13 | 13 | $5,005 | $1,230 | 24.6% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2023 | 35 | 35 | $3,045 | $1,136 | 37.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 13 | 13 | $2,392 | $615.03 | 25.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 13 | 13 | $2,249 | $587.73 | 26.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 13 | 13 | $2,483 | $416.78 | 16.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 16 | 16 | $656.00 | $130.56 | 19.9% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 14 | 14 | $406.00 | $99.12 | 24.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 125 | 125 | $43,750 | $15,366 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 90 | 137 | $37,127 | $12,706 | 34.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 17 | 42 | $24,486 | $7,107 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 89 | $16,999 | $5,908 | 34.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 34 | 39 | $14,742 | $5,018 | 34.0% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 30 | 30 | $7,523 | $2,913 | 38.7% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 27 | 27 | $6,594 | $2,446 | 37.1% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2022 | 72 | 72 | $6,806 | $2,271 | 33.4% |
About Dr. Jason Graff, M.D
Dr. Jason Graff, M.D is a Critical Care Medicine healthcare provider based in Narragansett, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316973100.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Graff, M.D has received a total of $7,596 in payments from pharmaceutical and medical device companies, with $2,044 received in 2024. These payments were reported across 155 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($3,598).
As a Medicare-enrolled provider, Graff has provided services to 2,917 Medicare beneficiaries, totaling 3,538 services with total Medicare billing of $303,581. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease, Pulmonary Disease
- Location Narragansett, RI
- Active Since 06/23/2006
- Last Updated 01/22/2025
- Taxonomy Code 207RC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1316973100
Products in Payments
- remede System (Device) $2,500
- Wakix (Drug) $1,514
- FASENRA (Biological) $1,114
- TEZSPIRE (Biological) $356.33
- SMARTVEST (Device) $228.60
- AIRSUPRA (Drug) $164.66
- DUPIXENT (Biological) $155.17
- WAKIX (Drug) $153.85
- NUCALA (Biological) $143.32
- TYVASO (Drug) $134.20
- Sunosi (Drug) $133.51
- YUPELRI (Drug) $128.58
- OFEV (Drug) $127.18
- BREZTRI (Drug) $104.78
- Xyrem (Drug) $97.97
- ELIQUIS (Drug) $96.89
- AIRSENSE (Device) $93.40
- XYWAV (Drug) $89.32
- SYMBICORT (Drug) $63.95
- INSPIRE (Device) $51.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.